Cervical artificial disc replacement for treatment of patients with cervical disc degenerative disease

Published on 01 May 2024
Last Updated on 01 May 2024

Guidance Recommendations

The Ministry of Health’s Medical Technology Advisory Committee has recommended cervical artificial disc replacement (C-ADR) for the treatment of symptomatic cervical disc degenerative disease (DDD) in line with the following criteria:

• Skeletally mature patients with symptomatic single level or two contiguous levels of cervical DDD and arm or neck pain (with or without neurologic deficit), confirmed by clinical examination and medical imaging, who:

  • require reconstruction of the cervical spinal disc;

  • have failed to respond to conservative medical management; and

  • have at least one of the following conditions:

    • herniated nucleus pulposus;

    • spondylosis (defined by the presence of osteophytes);

    • visible loss of disc height compared to adjacent levels; or

    • symptomatic spinal stenosis with radiculopathy.

Funding status

C-ADR is recommended for inclusion on the MOH Implant Subsidy List (ISL). Listed models are recommended for subsidy when used in line with the abovementioned recommendation.

Cervical artificial disc replacement for cervical disc degenerative disease (Published 1 May 2024) [PDF, 162 KB]